Luis Meillón
Impact in
- Hematology top 10%
- Chronic Myeloid Leukemia Treatments
- Platelet Disorders and Treatments
- Acute Myeloid Leukemia Research
-
- Chronic Lymphocytic Leukemia Research
- Blood disorders and treatments
Papers in
- Hematology 12
- Chronic Myeloid Leukemia Treatments 11
- Genetics 11
- Chronic Lymphocytic Leukemia Research 9
- Myeloproliferative Neoplasms: Diagnosis and Treatment 2
- Hemoglobinopathies and Related Disorders 1
- Co-authors
- Vicente Baca (1 shared paper)J Pizzuto (1 shared paper)Jörge E. Cortes (5 shared papers)Ricardo Pasqüini (4 shared papers)Kátia Bórgia Barbosa Pagnano (2 shared papers)Israel Bendit (1 shared paper)Timothy P. Hughes (6 shared papers)Nelson Hamerschlak (1 shared paper)
In The Last Decade
Luis Meillón
13 papers receiving 107 citations
Peers
Comparison fields: 5 of 25
- Hematology 93
- Genetics 55
- Rheumatology 48
- Internal Medicine 6
- Oncology 15
Countries citing papers authored by Luis Meillón
This map shows the geographic impact of Luis Meillón's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Luis Meillón with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Luis Meillón more than expected).
Fields of papers citing papers by Luis Meillón
This network shows the impact of papers produced by Luis Meillón. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Luis Meillón. The network helps show where Luis Meillón may publish in the future.
Co-authors
The 25 scholars most cited alongside Luis Meillón, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2002 | 36 | |
| 2 | 2010 | 20 | |
| 3 | 2017 | 16 | |
| 4 | 2021 | 13 | |
| 5 | 2014 | 8 | |
| 6 | 2012 | 4 | |
| 7 | 2011 | 3 | |
| 8 | 2015 | 3 | |
| 9 | [Treatment of cancer and thrombosis: practical approach]. | 2013 | 2 |
| 10 | Tromboembolia pulmonar en autopsias en un período de 10 años | 1996 | 2 |
| 11 | 2010 | 2 | |
| 12 | 2012 | 1 | |
| 13 | 2014 | 1 | |
| 14 | 1999 | 0 | |
| 15 | 2007 | 0 |
About Luis Meillón
Luis Meillón is a scholar working on Hematology, Genetics, Rheumatology, Public Health, Environmental and Occupational Health and Internal Medicine, having authored 15 papers that have together received 111 indexed citations. Recurring topics across this work include Chronic Myeloid Leukemia Treatments (11 papers), Chronic Lymphocytic Leukemia Research (9 papers), Acute Lymphoblastic Leukemia research (5 papers), Eosinophilic Disorders and Syndromes (4 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (2 papers), Venous Thromboembolism Diagnosis and Management (2 papers), Hemoglobinopathies and Related Disorders (1 paper) and Autopsy Techniques and Outcomes (1 paper). The work is most often cited by research in Hematology (93 citations), Genetics (55 citations), Rheumatology (48 citations), Internal Medicine (6 citations) and Oncology (15 citations). Luis Meillón has collaborated with scholars based in Mexico, Brazil and Australia. Frequent co-authors include Vicente Baca, J Pizzuto, Jörge E. Cortes, Ricardo Pasqüini, Kátia Bórgia Barbosa Pagnano, Israel Bendit, Timothy P. Hughes, Nelson Hamerschlak, Cármino Antônio De Souza and Carolina Pavlovsky. Their work appears in journals such as Blood, Cancer, British Journal of Haematology, American Journal of Hematology and Leukemia Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.